CHF5633

DB18696InvestigationalProtein Based Therapies

CHF5633 is a fully synthetic pulmonary surfactant preparation comprising DPPC (dipalmitoylphosphatidylcholine), POPG Na (palmitoyl‐oleoyl‐phosphatidylglycerol sodium), a synthetic SP-C analogue, and a synthetic SP-B analogue.

Code names: CHF-5633

What you can answer from here — as of April 23, 2025

2Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of CHF5633, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account